BioCentury
ARTICLE | Product Development

Oct. 25 Quick Takes: FDA approves Bausch + Lomb’s Xipere 

Plus AstraZeneca, AnaptysBio, Novartis, Sanofi and more

October 26, 2021 1:07 AM GMT
Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article